Trehalose
A disaccharide used for skin conditioning and moisture-related formulation, without a proven standalone anti-aging effect.

Trehalose is a disaccharide used in cosmetics for skin conditioning and moisture-related formulation. CIR's sugar-group assessment provides safety context for reported uses, not proof that trehalose alone reverses aging or treats dry-skin disease. A study of a trehalose derivative or an oral exposure is not automatically evidence for topical plain trehalose.1
- A disaccharide, not a peptide or an exfoliating acid.1
- Included in a cosmetic sugar-group assessment published in 2019.1
- A group safety conclusion does not establish comparative moisturizer efficacy.1
What is Trehalose?
A small sugar can be useful to a formula without being a headline medical active. Trehalose's relevance here is topical material behavior and conditioning. Discussions about food, metabolism or modified trehalose molecules concern different interventions and need separate evidence rather than one broad trehalose benefit list.1
Where it comes from
Natural sources
- Occurs in various biological materials, including microorganisms
How it's made
Commercial trehalose is produced and purified for the intended food or cosmetic grade.
What it does in products
Benefits
Conditioning within a finished moisturizer
limited evidenceTrehalose has a documented cosmetic role, but any measured hydration improvement must be linked to a tested preparation.1
The cited report assesses sugars as cosmetic ingredients. It is not a randomized comparison proving trehalose outperforms glycerin or produces an independent anti-aging benefit.
Evidence scope and limitations
Plain topical trehalose and the cosmetic sugar-group assessment; excludes oral disease claims and modified trehalose derivatives.
- Group safety evidence is not a comparative efficacy trial.
- No independent clinical effect or optimal consumer concentration is inferred.
Evidence last checked: 2026-10-01
Side effects & safety
Safety considerations
- Oral trehalose metabolism and topical cosmetic exposure are different questions.
- Evidence about sodium trehalose sulfate or another derivative should remain attached to that derivative.
- Not for: Avoid a product after a reproducible reaction; do not infer that a sugar-containing serum is sterile or safe to ingest.
Amounts studied & product use
These figures describe research or common product use, not a personal dose or treatment recommendation.
In skincare studies and products
No evidence-based universally optimal topical percentage is established by the cited safety report. Reported cosmetic uses are not a personal dose or permission to recreate a raw-material formula.
Regulatory status
- A U.S. cosmetic ingredient subject to formula-safety and labeling requirements. Food use does not grant a skincare disease-treatment claim.
- INCI name on cosmetic labels: Trehalose.
- Included in the 2019 monosaccharide/disaccharide group assessment under reported uses.
Do not borrow a derivative's trial
Changing a molecule can change its properties and exposure. If a paper studies a trehalose salt or substituted derivative, the intervention name belongs in the claim.
The same applies to multi-ingredient moisturizers. An improved outcome with a complete cream cannot establish that trehalose alone caused the change without an appropriate control.
1Frequently asked questions
The bottom line
Trehalose can serve a useful formulation role without needing an unsupported standalone anti-aging promise.
References
- Fiume MM, Bergfeld WF, Belsito DV et al.. Safety Assessment of Monosaccharides, Disaccharides, and Related Ingredients as Used in Cosmetics. International Journal of Toxicology / Cosmetic Ingredient Review (2019) · safety assessment · PMID 31170840; DOI 10.1177/1091581818814189
- Allergens in Cosmetics. U.S. Food and Drug Administration · government guidance · Undated live resource; accessed October 1, 2026
- FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated. U.S. Food and Drug Administration (2013) · government guidance · Page updated August 3, 2013; accessed October 1, 2026
Revision history
- Initial AI-assisted evidence compilation with source-linked claims, formulation distinctions and explicit research limitations; not independent medical review.